Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.28 -0.14 (-3.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Total Non-Current Liabilities (2016 - 2024)

Updated

Corbus Pharmaceuticals Holdings' Total Non-Current Liabilities was $13.45 million in Q4 2024, down 61.7% from $35.13 million a year earlier and down 1.6% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Total Non-Current Liabilities (2016 - 2024) Analysis & Trends

From Q1 2016 onward, Corbus Pharmaceuticals Holdings has reported Total Non-Current Liabilities for 29 quarters.

  • Total Non-Current Liabilities shows a four-year compound annual growth rate of -30.3% (FY2020 to FY2024).
  • In earlier years, Total Non-Current Liabilities was $35.13 million in FY2023 (+5.5%), $33.3 million in FY2022 (-13.7%), $38.6 million in FY2021 (-32.3%) and $57.02 million in FY2020.
  • The Q4 2024 figure marks the lowest quarterly Total Non-Current Liabilities since Q2 2018.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for four straight quarters, with an average decline of 17.5% over the last eight quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q3 2023 (growth of 12.8%); the worst was Q3 2024 (a decline of 61.9%).
  • Per Business Quant data, CRBP's Total Non-Current Liabilities in the three quarters before Q4 2024 was $13.67 million (Q3 2024), $26.44 million (Q2 2024) and $28.78 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Corbus Pharmaceuticals Holdings 52.74 Mn -463.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 13.45 Mn
Sep 30, 2024 13.67 Mn
Jun 30, 2024 26.44 Mn
Mar 31, 2024 28.78 Mn
Dec 31, 2023 35.13 Mn
Sep 30, 2023 35.93 Mn
Jun 30, 2023 34.18 Mn
Mar 31, 2023 32.66 Mn
Dec 31, 2022 33.30 Mn
Sep 30, 2022 31.86 Mn
Jun 30, 2022 32.57 Mn
Mar 31, 2022 34.50 Mn
Dec 31, 2021 38.60 Mn
Sep 30, 2021 41.82 Mn
Jun 30, 2021 43.05 Mn
Mar 31, 2021 47.83 Mn
Dec 31, 2020 57.02 Mn
Dec 31, 2018 19.44 Mn
Sep 30, 2018 16.93 Mn
Jun 30, 2018 13.45 Mn
API Access

Corbus Pharmaceuticals Holdings Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CRBP&period=max&api_key=YOUR_API_KEY